Is Ozempic a Peptide? What It Means and Why It Matters

Written by Dr. Sheri Tomas. Updated October 22, 2026.

Yes. The active ingredient in Ozempic, semaglutide, is a peptide: a chain of 31 amino acids built as a modified copy of GLP-1, a hormone your gut makes after meals. That single fact explains a lot about the drug, from why it's an injection to why it has to be kept cold and why it lasts a whole week.

But "peptide" has also become a marketing word. Wellness clinics and websites now sell "peptides" as a category, sometimes with semaglutide in the same list as unapproved compounds. Being a peptide doesn't make those products anything like Ozempic. Here's what the label means and where the line is.

Peptides and proteins are both made of amino acids linked in a chain. The difference is length. Peptides are short chains; proteins are long ones that fold into complex shapes. Many hormones in your body are peptides, including insulin, glucagon and GLP-1.

U.S. law draws the line at 40 amino acids. Since March 2020, FDA has treated anything longer as a protein, regulated as a biologic, and anything 40 or shorter as a peptide, regulated as a regular drug. That's why insulin moved to the biologics pathway in 2020, while semaglutide, at 31 amino acids, is approved as a standard drug. It sounds technical, but it matters for generics, as you'll see below.

Natural GLP-1 lasts about two minutes in the blood before an enzyme called DPP-4 breaks it down. Semaglutide keeps about 94% of the same structure but has three deliberate changes that stretch its half-life to about a week.

The result is a half-life of about 165 hours, which is why Ozempic is a once-weekly shot. For what the molecule does once it reaches its receptor, see how Ozempic works and our explainer on GLP-1.

Novo Nordisk doesn't extract semaglutide from anything. According to the European product information, the peptide backbone is produced by yeast cells using recombinant DNA technology, and the fatty acid side chain is then attached chemically. It's a precise, heavily controlled process, and it's one reason the supply couldn't simply be scaled up overnight during the shortage.

Search for peptides online and you'll find clinics and shops selling BPC-157, TB-500, ipamorelin and similar compounds, often next to semaglutide or tirzepatide. That shelf placement is misleading. Ozempic went through large clinical trials involving tens of thousands of people; most of the popular wellness peptides have little or no human trial data and aren't FDA-approved for any use.

The rules are also in flux. In February 2026, HHS announced plans to move about 14 peptides, including BPC-157 and TB-500, off FDA's restricted compounding list, and in July an FDA advisory committee voted to recommend several of them. Those steps would allow compounding with a prescription, not approval, and the committee vote isn't binding. Separately, FDA moved in February 2026 to restrict mass-marketed compounded semaglutide and tirzepatide.

"Research use only" means the seller is saying the product isn't meant for people. Independent testing of gray-market peptide vials has found bacterial contamination, solvent residue and doses below the label. If you're considering compounded semaglutide instead of Ozempic, read our compounded semaglutide guide first.

Ozempic is a peptide drug: semaglutide is a 31-amino-acid, lab-made version of the GLP-1 hormone, engineered to last a week. That's why it's injected, why it needs careful storage, and why generics will follow the standard drug route. But sharing the word "peptide" doesn't put Ozempic in the same category as unapproved wellness peptides or unregulated vials sold online. For a broader overview, start with What Is Ozempic?.